{"tool_name":"d3similarity","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"d3similarity","home":"https://www.d3pharma.com/D3Targets-2019-nCoV/D3Similarity/index.php","summary":"D3Similarity is A Ligand-Based Approach for Predicting Drug Targets and for Virtual Screening of Active Compounds Against COVID-19. D3Similarity was developed with two purposes based on the two-dimensional and three-dimensional similarity of molecular structure, one is for predicting target proteins for active compounds observed from experimental studies, and another is for virtual screening via 2D and 3D similarity evaluation. To this end, we developed a database composed of the bioactive molecules with known targets or/and well-explored mechanism related to the whole process of coronavirus infection, replication and release. \u201cTargetPrediction\u201d is for predicting target proteins, while \u201cVirtualScreening\u201d is for virtual screening against target proteins based on the 2D or 3D similarity evaluation.","addition_date":"2021-01-18T07:58:51Z","last_update_date":"2021-02-22T14:30:18Z","tool_type":["Web application"],"collections":["COVID-19"]},"bioschemas":{"name":"D3Similarity","home":"https://bio.tools/d3similarity","summary":"D3Similarity is A Ligand-Based Approach for Predicting Drug Targets and for Virtual Screening of Active Compounds Against COVID-19. D3Similarity was developed with two purposes based on the two-dimensional and three-dimensional similarity of molecular structure, one is for predicting target proteins for active compounds observed from experimental studies, and another is for virtual screening via 2D and 3D similarity evaluation. To this end, we developed a database composed of the bioactive molecules with known targets or/and well-explored mechanism related to the whole process of coronavirus infection, replication and release. \u201cTargetPrediction\u201d is for predicting target proteins, while \u201cVirtualScreening\u201d is for virtual screening against target proteins based on the 2D or 3D similarity evaluation.","tool_type":"sc:SoftwareApplication"}}}